SUNRISE, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) a leader in the field of stem cell therapy for the treatment of damaged hearts, today announced that it entered into a $3M standby equity purchase agreement, previously announced in October.
